Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

Healthcare
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

Recent & Breaking News (TSXV:RX)

Combogesic® - First Acetaminophen + Ibuprofen Combination Tablet - Now Available for Canadians with Acute Pain

Canada NewsWire March 16, 2021

BioSyent Schedules Q4 and Full Year 2020 Earnings Release for March 17, 2021

GlobeNewswire March 11, 2021

BioSyent Launches Combogesic®, First-Ever Acetaminophen + Ibuprofen Combination Tablet in Canada Now Available

GlobeNewswire December 16, 2020

BioSyent Announces Renewal of Normal Course Issuer Bid

GlobeNewswire December 11, 2020

BioSyent Releases Financial Results for Third Quarter and First Nine Months of 2020

GlobeNewswire November 26, 2020

BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020

GlobeNewswire November 17, 2020

Biosyent Announces Launch of New FeraMAX® Pd Therapeutic 150

GlobeNewswire November 5, 2020

BioSyent Named to the Growth List Ranking of Canada's Fastest-Growing Companies for Eighth Consecutive Year

GlobeNewswire October 15, 2020

BioSyent Announces Introduction of New FeraMAX® Pd

GlobeNewswire October 5, 2020

BioSyent Signs Exclusive Agreement for New Women's Health Product

GlobeNewswire October 1, 2020

LD Micro - 360 Companies Set to Present this Week

Accesswire August 31, 2020

BioSyent Releases Q2 and H1 2020 Results

GlobeNewswire August 26, 2020

BioSyent to Present at the LD 500 Virtual Conference

GlobeNewswire August 24, 2020

BioSyent Schedules Q2 and H1 2020 Earnings Release for August 26, 2020

GlobeNewswire August 17, 2020

LD Micro Announces Preliminary List of Presenters for the LD 500

Accesswire August 5, 2020

BioSyent Announces the Availability of Tibella® (tibolone) in Canada

GlobeNewswire July 29, 2020

BioSyent Releases Results for Q1 2020

GlobeNewswire May 28, 2020

BioSyent Schedules Q1 2020 Earnings Release For May 28, 2020

GlobeNewswire May 21, 2020

FeraMAX® Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Fifth Consecutive Year

GlobeNewswire May 1, 2020

BIOSYENT ANNOUNCES GRANT OF RESTRICTED SHARE UNITS

GlobeNewswire March 31, 2020